Compare Stocks: FMS, DVA, and PGNY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVA DaVita	$183.59 +0.3%	$199.60	$101.00 ▼ $247.49	$11.73B	0.83	637,614 shs	2.10 million shs
FMS Fresenius Medical Care AG & Co. KGaA	$22.21 +0.6%	$23.66	$20.02 ▼ $27.64	$11.92B	0.76	608,360 shs	818,573 shs
PGNY Progyny	$27.13 +0.4%	$28.37	$16.10 ▼ $33.06	$2.08B	0.99	972,112 shs	3.14 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVA DaVita	0.00%	+1.12%	+4.59%	-11.58%	+43.44%
FMS Fresenius Medical Care AG & Co. KGaA	0.00%	-0.67%	-5.23%	-5.88%	-13.13%
PGNY Progyny	0.00%	-0.80%	+4.51%	+4.03%	+25.43%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DVA DaVita	$183.59 +0.3%	$199.60	$101.00 ▼ $247.49	$11.73B	0.83	637,614 shs	2.10 million shs
FMS Fresenius Medical Care AG & Co. KGaA	$22.21 +0.6%	$23.66	$20.02 ▼ $27.64	$11.92B	0.76	608,360 shs	818,573 shs
PGNY Progyny	$27.13 +0.4%	$28.37	$16.10 ▼ $33.06	$2.08B	0.99	972,112 shs	3.14 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DVA DaVita	0.00%	+1.12%	+4.59%	-11.58%	+43.44%
FMS Fresenius Medical Care AG & Co. KGaA	0.00%	-0.67%	-5.23%	-5.88%	-13.13%
PGNY Progyny	0.00%	-0.80%	+4.51%	+4.03%	+25.43%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DVA DaVita	2.57	Moderate Buy	$233.43	27.14% Upside
FMS Fresenius Medical Care AG & Co. KGaA	1.55	Reduce	$23.57	6.13% Upside
PGNY Progyny	2.85	Moderate Buy	$34.36	26.66% Upside

Current Analyst Ratings Breakdown

Latest FMS, DVA, and PGNY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/8/2026	PGNY Progyny	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
9/8/2026	PGNY Progyny	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$33.00
9/8/2026	PGNY Progyny	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Outperform	$31.00 ➝ $33.00
9/2/2026	PGNY Progyny	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
8/31/2026	PGNY Progyny	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C+) ➝ Hold (C)
8/21/2026	PGNY Progyny	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$27.00 ➝ $30.00
8/20/2026	PGNY Progyny	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$37.00
8/20/2026	PGNY Progyny	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$37.00
8/13/2026	PGNY Progyny	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/13/2026	PGNY Progyny	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$33.00 ➝ $36.00
8/7/2026	DVA DaVita	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$201.00 ➝ $220.00

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DVA DaVita	$13.64B	0.86	$21.68 per share	8.47	($5.29) per share	-34.71
FMS Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$5.57 per share	3.99	$28.93 per share	0.77
PGNY Progyny	$1.29B	1.62	$0.74 per share	36.85	$5.99 per share	4.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DVA DaVita	$746.80M	$12.22	15.02	10.64	0.48	6.05%	-217.63%	5.07%	10/28/2026 (Estimated)
FMS Fresenius Medical Care AG & Co. KGaA	$1.11B	$1.93	11.51	9.45	4.12	4.83%	9.28%	4.16%	11/3/2026 (Estimated)
PGNY Progyny	$58.52M	$0.92	29.49	19.11	1.87	6.00%	15.98%	10.65%	11/5/2026 (Estimated)

Latest FMS, DVA, and PGNY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	PGNY Progyny	$0.3348	$0.55	+$0.2152	$0.34	$349.05 million	$350.51 million
8/4/2026	Q2 2026	DVA DaVita	$3.88	$4.02	+$0.14	$4.02	$3.50 billion	$3.55 billion
8/3/2026	Q2 2026	FMS Fresenius Medical Care AG & Co. KGaA	$0.6160	$0.66	+$0.0440	$0.46	$5.48 billion	$5.55 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DVA DaVita	N/A	N/A	N/A	N/A	N/A
FMS Fresenius Medical Care AG & Co. KGaA	$0.61	2.75%	+2.66%	31.61%	N/A
PGNY Progyny	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DVA DaVita	N/A	1.47	1.41
FMS Fresenius Medical Care AG & Co. KGaA	0.43	1.07	0.75
PGNY Progyny	N/A	2.14	2.14

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DVA DaVita	90.12%
FMS Fresenius Medical Care AG & Co. KGaA	8.37%
PGNY Progyny	94.93%

Insider Ownership

Company	Insider Ownership
DVA DaVita	1.90%
FMS Fresenius Medical Care AG & Co. KGaA	N/A
PGNY Progyny	9.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DVA DaVita	78,000	63.80 million	62.59 million	Optionable
FMS Fresenius Medical Care AG & Co. KGaA	1,488	537.13 million	N/A	Optionable
PGNY Progyny	856	76.73 million	69.13 million	Optionable

FMS, DVA, and PGNY Headlines

Recent News About These Companies

Wall Street Zen Upgrades Progyny (NASDAQ:PGNY) to "Strong-Buy"

September 19 at 1:13 AM | americanbankingnews.com

Progyny (NASDAQ:PGNY) Upgraded at Wall Street Zen

September 19 at 1:11 AM | marketbeat.com

Progyny (PGNY) Stock Looks Fairly Valued Despite Its 57% Five Year Slide

September 18 at 1:40 PM | finance.yahoo.com

PGNY vs. CRL: Which Stock Is the Better Value Option?

September 18 at 12:40 PM | zacks.com

Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027

September 17 at 12:00 PM | seekingalpha.com

Squarepoint Ops LLC Purchases Shares of 59,139 Progyny, Inc. $PGNY

September 16, 2026 | marketbeat.com

Progyny (NASDAQ:PGNY) Director Kevin Gordon Sells 11,500 Shares

September 15, 2026 | americanbankingnews.com

Insider Selling: Progyny (NASDAQ:PGNY) Director Sells $321,310.00 in Stock

September 15, 2026 | insidertrades.com

Kevin Gordon Sells 11,500 Shares of Progyny (NASDAQ:PGNY) Stock

September 14, 2026 | marketbeat.com

41,200 Shares in Progyny, Inc. $PGNY Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al

September 13, 2026 | marketbeat.com

Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2

September 10, 2026 | finance.yahoo.com

Progyny, Inc. $PGNY Position Boosted by WINTON GROUP Ltd

September 10, 2026 | marketbeat.com

Progyny (NASDAQ:PGNY) Stock Price Expected to Rise, Citizens Jmp Analyst Says

September 10, 2026 | americanbankingnews.com

Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know

September 9, 2026 | zacks.com

Progyny (NASDAQ:PGNY) Price Target Raised to $33.00 at Citizens Jmp

September 8, 2026 | marketbeat.com

Progyny: Slow But Consistent Growth With A Pristine Balance Sheet

September 5, 2026 | seekingalpha.com

Wellington Management Group LLP Sells 790,748 Shares of Progyny, Inc. $PGNY

September 4, 2026 | marketbeat.com

Legal & General Group Plc Invests $4.67 Million in Progyny, Inc. $PGNY

September 4, 2026 | marketbeat.com

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

September 3, 2026 | globenewswire.com

Corient Private Wealth LP Takes $3.17 Million Position in Progyny, Inc. $PGNY

September 2, 2026 | marketbeat.com

Bank of New York Mellon Corp Makes New $11.93 Million Investment in Progyny, Inc. $PGNY

September 2, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

FMS, DVA, and PGNY Company Descriptions

DaVita NYSE:DVA

$183.59 +0.50 (+0.27%)

Closing price 09/18/2026 03:59 PM Eastern

Extended Trading

$183.73 +0.14 (+0.07%)

As of 09/18/2026 07:46 PM Eastern

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$22.20 +0.14 (+0.61%)

Closing price 09/18/2026 03:59 PM Eastern

Extended Trading

$22.20 0.00 (-0.02%)

As of 09/18/2026 07:30 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Progyny NASDAQ:PGNY

$27.13 +0.12 (+0.44%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$27.12 0.00 (-0.02%)

As of 09/18/2026 07:37 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FMS, DVA, and PGNY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FMS, DVA, and PGNY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FMS, DVA, and PGNY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

FMS, DVA, and PGNY Company Descriptions

DaVita NYSE:DVA

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Progyny NASDAQ:PGNY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FMS, DVA, and PGNY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FMS, DVA, and PGNY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FMS, DVA, and PGNY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

FMS, DVA, and PGNY Company Descriptions

DaVita NYSE:DVA

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Progyny NASDAQ:PGNY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools